# TRUH holdings: all 60 positions

> As of Jun 30, 2026, TRUH’s top 10 holdings were 61.7% of the fund. The largest were Eli Lilly & Co 16.56%, Johnson & Johnson 10.67% and AbbVie Inc 7.76%.

Data as of Jun 30, 2026. Rebuilt every trading night.

As of Jun 30, 2026, TRUH’s top 10 holdings were 61.7% of the fund, led by Eli Lilly & Co at 16.56%. It held 60 positions.

Source: Form N-PORT filed with the SEC (<https://www.sec.gov/Archives/edgar/data/1137360/000141036826086932/primary_doc.xml>).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 16.56% |
| 2 | Johnson & Johnson | JNJ | 10.67% |
| 3 | AbbVie Inc | ABBV | 7.76% |
| 4 | UnitedHealth Group Inc | UNH | 6.58% |
| 5 | Merck & Co Inc | MRK | 5.54% |
| 6 | Amgen Inc | AMGN | 3.39% |
| 7 | Thermo Fisher Scientific Inc | TMO | 3.25% |
| 8 | Abbott Laboratories | ABT | 2.76% |
| 9 | Gilead Sciences Inc | GILD | 2.75% |
| 10 | Intuitive Surgical Inc | ISRG | 2.48% |
| 11 | Pfizer Inc | PFE | 2.40% |
| 12 | CVS Health Corp | CVS | 2.31% |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 2.21% |
| 14 | Danaher Corp | DHR | 2.10% |
| 15 | Bristol-Myers Squibb Co | BMY | 2.05% |
| 16 | Stryker Corp | SYK | 1.89% |
| 17 | Medtronic PLC | MDT | 1.76% |
| 18 | McKesson Corp | MCK | 1.54% |
| 19 | Elevance Health Inc | ELV | 1.49% |
| 20 | Cigna Group | CI | 1.26% |
| 21 | Regeneron Pharmaceuticals Inc | REGN | 1.12% |
| 22 | Boston Scientific Corp | BSX | 1.11% |
| 23 | HCA Healthcare Inc | HCA | 1.08% |
| 24 | Cardinal Health Inc | CAH | 0.97% |
| 25 | Cencora Inc | COR | 0.95% |
| | Cash and other net assets | | 0.09% |

The largest 25 of 60 positions are shown. All of them: https://etfiq.com/funds/truh/holdings/truh-holdings.csv (CSV) or https://etfiq.com/data/books/truh.json (JSON).

Fund page: https://etfiq.com/funds/truh

Cite: ETFIQ, Holdings of TRUH, data as of Jun 30, 2026. https://etfiq.com/funds/truh/holdings/